Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Bennink

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Fertility and Sterility|March 1, 1979
Intermittent bromocriptine treatment for the induction of ovulation in hyperprolactinemic patientsH J Bennink
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|March 15, 2001
The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implantH J Bennink
Steroids|December 8, 2000
The Jerusalem declaration on progesterone receptor modulatorsH J Bennink
British Medical Journal|July 5, 1975
Improvement of oral glucose tolerance in gestational diabetes by pyridoxineH J Bennink, W H Schreurs
Contraception|April 1, 1974
Disturbance of tryptophan metabolism and its correction during hormonal contraceptionH J Bennink, W H Schreurs
Climacteric : the Journal of the International Menopause Society|June 29, 2001
Tibolone and its effects on bone: a reviewB Berning, H J Bennink, B C Fauser
Lancet (London, England)|May 29, 1976
Letter: Bromocriptine regimen for restoration of ovulatory functionH J Bennink, A A Haspels, H Snuiverink
Lancet (London, England)|March 5, 1977
Bromocriptine for induction of ovulation in normoprolactinaemic post-pill anovulationH J van der Steeg, H J Bennink
Maturitas|June 1, 1978
Disturbance of tryptophan metabolism and its correction during oestrogen treatment in postmenopausal womenA A Haspels, H J Bennink, W H Schreurs
Fertility and Sterility|February 1, 1997
A prospective, randomized study to assess the tolerance and efficacy of intramuscular and subcutaneous administration of recombinant follicle-stimulating hormone (Puregon)H J Out, P E Reimitz, H J Bennink
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Fertility and Sterility|March 1, 1979
Intermittent bromocriptine treatment for the induction of ovulation in hyperprolactinemic patientsH J Bennink
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|March 15, 2001
The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implantH J Bennink
Steroids|December 8, 2000
The Jerusalem declaration on progesterone receptor modulatorsH J Bennink
British Medical Journal|July 5, 1975
Improvement of oral glucose tolerance in gestational diabetes by pyridoxineH J Bennink, W H Schreurs
Contraception|April 1, 1974
Disturbance of tryptophan metabolism and its correction during hormonal contraceptionH J Bennink, W H Schreurs
Climacteric : the Journal of the International Menopause Society|June 29, 2001
Tibolone and its effects on bone: a reviewB Berning, H J Bennink, B C Fauser
Lancet (London, England)|May 29, 1976
Letter: Bromocriptine regimen for restoration of ovulatory functionH J Bennink, A A Haspels, H Snuiverink
Lancet (London, England)|March 5, 1977
Bromocriptine for induction of ovulation in normoprolactinaemic post-pill anovulationH J van der Steeg, H J Bennink
Maturitas|June 1, 1978
Disturbance of tryptophan metabolism and its correction during oestrogen treatment in postmenopausal womenA A Haspels, H J Bennink, W H Schreurs
Fertility and Sterility|February 1, 1997
A prospective, randomized study to assess the tolerance and efficacy of intramuscular and subcutaneous administration of recombinant follicle-stimulating hormone (Puregon)H J Out, P E Reimitz, H J Bennink
Pageof 3